A cohort study to evaluate the efficacy and safety of entecavir and tenofovir disoproxil fumarate in chronic hepatitis B patients

Trial Profile

A cohort study to evaluate the efficacy and safety of entecavir and tenofovir disoproxil fumarate in chronic hepatitis B patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 May 2016 New trial record
    • 17 Apr 2016 Results (n=621) of virologic and serologic responses of patients with multi-drug resistance versus treatment-naive patients were presented at The International Liver Congress™ 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top